Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01733641 · ClinicalTrials.gov registry record
Test-Retest Reliability in DETECT
A clinical trial, sponsored by Emory University.
- Terminated
- Registry status
- 44
- Enrollment target
NCT01733641: Clinical Trial study, sponsored by Emory University.
NCT01733641 is a clinical trial that was terminated before completion, run by Emory University. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01733641 was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- 44 participants
- Enrollment target
Study Summary
Healthy volunteers without concussion, currently participating in non-or-limited contact sports teams at Emory University will undergo Display Enhanced Testing for Concussion and mild traumatic brain injury (mTBI) (DETECT) on three separate days: at baseline, day 50, and day 90. Prior to enrollment participants will be allocated to the test-retest arm or the exercise arm.
Primary Outcome
Subjects will complete the DETECT cognitive assessment tool at Baseline, 50 days, and 90 days.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-04 |
Why NCT01733641 stopped before completion
NCT01733641 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01733641 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01733641 about?
NCT01733641 is a clinical study titled "Test-Retest Reliability in DETECT". Healthy volunteers without concussion, currently participating in non-or-limited contact sports teams at Emory University will undergo Display Enhanced Testing for Concussion and mild traumatic brain injury (mTBI) (DETECT) on three separate days: at baseline, day 50, and day 90. Prior to enrollment ...
What is the current status of trial NCT01733641?
This trial is currently terminated. The enrollment target is 44 participants. The study started on 2011-09. Estimated completion is 2013-04.
Who is sponsoring clinical trial NCT01733641?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia